GenSight Biologics Announces Update on Real-World Data from Early Access Programs of LUMEVOQ® Gene Therapy at NANOS 2024
                                    Clinically meaningful improvement in visual acuity confirmed in a real-world setting: on-chart mean visual acuity at 9 months after injection, compared to off-chart... Read more.                                
                            
                                                            
                            
                            
                            
                        
                                                    Galderma Announces Intention to Float on the SIX Swiss Exchange
                                    ZUG, Switzerland–(BUSINESS WIRE)–Galderma Group AG: NOT FOR RELEASE, PUBLICATION OR DISTRIBUTION, IN WHOLE OR IN PART, DIRECTLY OR INDIRECTLY, IN THE... Read more.                                
                            
                                                            
                            
                            
                            
                        
                                                    Wolters Kluwer wins Best Regulatory Compliance Solution for IFRS 9 at the RegTech Insight APAC Awards
                                     Finance, Risk and Regulatory Reporting’s OneSumX product recognized for its IFRS 9 innovations SINGAPORE–(BUSINESS WIRE)–#ECL–Wolters... Read more.                                
                            
                                                            
                            
                            
                            
                        Nordson Electronics Solutions to Demonstrate Plasma Treatment and Automated Fluid Dispensing Systems for Electronics Manufacturing at SEMICON China 2024
                                    Connect with our experts and see plasma and dispensing equipment for microelectronics manufacturing in booth 3645 CARLSBAD, Calif.–(BUSINESS WIRE)–#nordsonelectronics—Nordson... Read more.                                
                            
                                                            
                            
                            
                            
                        
                                                    Innate Pharma: First Patient dosed in Phase 1/2 study of IPH6501 in relapsed /refractory B-Cell non-Hodgkin’s Lymphoma
                                    Phase 1/2 study is evaluating IPH6501, a first-in-class CD20-targeting tetraspecific natural killer cell engager, from ANKET® platform, for the treatment of... Read more.                                
                            
                                                            
                            
                            
                            
                        
                                                    Innate Pharma to Present Nectin-4 Antibody Drug Conjugate IPH45 Preclinical Data at AACR 2024
                                    IPH45 abstract selected for oral presentation at AACR Annual Meeting 2024 Preclinical data support further development of IPH45, a differentiated topoisomerase I... Read more.                                
                            
                                                            
                            
                            
                            
                        
                                                    MCO (MyComplianceOffice) Wins Best eComms Surveillance Solution in the APAC RegTech Insight Awards
                                    SINGAPORE–(BUSINESS WIRE)–#asiarisk–Global compliance technology provider MCO (MyComplianceOffice) has been awarded Best eComms Surveillance Solution... Read more.                                
                            
                                                            
                            
                            
                            
                        
                                                    Tandem Diabetes Care Prices Upsized Private Placement of $275.0 Million of Convertible Senior Notes Due 2029
                                    SAN DIEGO–(BUSINESS WIRE)–Tandem Diabetes Care, Inc. (NASDAQ: TNDM), a global insulin delivery and diabetes technology company, announced today the pricing... Read more.                                
                            
                                                            
                            
                            
                            
                        
                                                    Kioxia Selected in 2024 Edition of Clarivate Top 100 Global Innovators™
                                    TOKYO–(BUSINESS WIRE)–Kioxia Corporation has been named a Clarivate Top 100 Global Innovators™ 2024, an award given to the most innovative global... Read more.                                
                            
                                                            
                            
                            
                            
                        
                                                    Liberty Global Appoints Severina Pascu as Senior Vice President, Commercial & Operations
                                    DENVER, Colorado–(BUSINESS WIRE)–Liberty Global Ltd. (Liberty Global) (NASDAQ: LBTYA, LBTYB and LBTYK) announces today that Severina Pascu has been appointed... Read more.